| __timestamp | Intra-Cellular Therapies, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 382096000000 |
| Thursday, January 1, 2015 | 87718074 | 345927000000 |
| Friday, January 1, 2016 | 93831530 | 312303000000 |
| Sunday, January 1, 2017 | 79419009 | 325441000000 |
| Monday, January 1, 2018 | 132166913 | 368298000000 |
| Tuesday, January 1, 2019 | 89124838 | 492381000000 |
| Wednesday, January 1, 2020 | 65782137 | 455833000000 |
| Friday, January 1, 2021 | 88845513 | 526087000000 |
| Saturday, January 1, 2022 | 134715000 | 633325000000 |
| Sunday, January 1, 2023 | 180142000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Intra-Cellular Therapies, Inc. have demonstrated contrasting strategies in their R&D investments. Takeda, a global leader, has consistently allocated substantial resources, with a notable 91% increase in R&D expenses from 2014 to 2023. In contrast, Intra-Cellular Therapies, a smaller player, has shown a remarkable 750% surge in R&D spending over the same period, reflecting its aggressive pursuit of growth and innovation. While Takeda's R&D budget dwarfs that of Intra-Cellular, the latter's rapid increase underscores its strategic focus on breakthrough therapies. This divergence in R&D strategies highlights the dynamic nature of the pharmaceutical industry, where both scale and agility play pivotal roles in shaping the future of healthcare.
Comparing Innovation Spending: AbbVie Inc. and Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.